Literature DB >> 1165648

The value of cells in the pleural fluid in the differential diagnosis.

D E Dines, R V Pierre, S J Franzen.   

Abstract

Fifty samples of pleural fluid, collected from consecutive patients in a thoracic clinic who had diagnostic thoracentesis, were studied prospectively. Pleural fluid protein was of value in differentiating transudates from exudates. Pleural fluid red cell counts, white blood cell counts, and differential white blood cell counts have no specificity and no usefulness in the differential diagnosis of the origin of the effusion. Pleural fluid cytology was positive in 60% of all the malignancies studied in this series; for the group with metastatic breast carcinoma, there was a 78% positive pleural fluid cytology. Differential white cell counts revealed tumor cells in 45% of malignant effusions. In our experience, the finding of tumor cells is the only useful finding in differential cell counts of the pleural fluid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165648

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

Review 1.  The role of thoracoscopy in the evaluation and management of pleural effusions.

Authors:  C Boutin; P Astoul; B Seitz
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Neutrophil elastase alpha 1-proteinase inhibitor complexes in pleural effusions.

Authors:  H Klech; G Rona; E Knoth; F Kummer; P M Bayer
Journal:  Klin Wochenschr       Date:  1988-04-15

3.  A comparative study of lymphocytes in effusions of patients with tuberculosis or malignant disease.

Authors:  R P Falcão; C Bottura
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

4.  Pleural effusion: laboratory tests in 300 cases.

Authors:  A Hirsch; P Ruffie; M Nebut; J Bignon; J Chrétien
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

Review 5.  Approach to Diagnostic Cytopathology of Serous Effusions.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.